Thomas McGrath

Nov 28, 2024 | mondaq.com | Thomas McGrath |Antonia Sherman |John Eichlin

After more than two years of drafting, the Federal Trade Commission (FTC) released the final changes to the Hart-Scott-Rodino (HSR) filing form late last week. The final rule is still a significant expansion of the HSR filing requirements, but it pares back some of the more onerous requirements of the proposed rule. The changes are expected to go into effect in mid-January 2025, but legal challenges could extend this timing.

May 20, 2024 | mondaq.com | Thomas McGrath |Antonia Sherman |Douglas Tween |John Eichlin

For the first time in its history, the US Federal Trade Commission issued a final rule governing unfair methods of competition. In line with its ambitious approach towards its Section 5 enforcement, the FTC will ban almost all non-compete agreements between employers and employees—if the rule survives legal challenge. We discuss what dealmakers need to know about this new rule and how non-competes are treated around the world.

Apr 9, 2024 | mondaq.com | Thomas McGrath |Antonia Sherman

Is there space in healthcare for private equity participation? If you listened to the Federal Trade Commission's recent workshop, their answer may appear to be "none". But we think enforcers have a narrower focus than their rhetoric suggests, both in nature and in scope. Under the current Administration, both antitrust agencies have taken an aggressive enforcement posture against private equity in general.

Dec 16, 2023 | manchestermill.co.uk | Thomas McGrath

By Dr Thomas McGrathThe state of her neighbour’s health had played on the mind of Mary Warren all night. She could not shake the image of 74-year-old Clara Alice Jones shuffling around her back yard looking pale and unwell. In the morning Mary went next door to check on the elderly lady, but no one answered her persistent knocking. Alarmed, she went to find a public telephone to call Mr Wolstenholme, Clara’s solicitor and her only known familial connection.

Oct 6, 2023 | mondaq.com | Antonia Sherman |William Huynh |Thomas McGrath |John Eichlin

After years of strong rhetoric, the Federal Trade Commission has announced new enforcement targeting what they describe as a scheme to suppress competition through a series of non-reportable roll-up and bolt-on acquisitions. On September 21, the FTC filed a complaint against U.S. Anesthesiology Partners (USAP) and its largest investor, private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson).